Variant report
Variant | nsv968826 |
---|---|
Chromosome Location | chr5:42040753-42046427 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:42037141..42039596-chr5:42040271..42043042,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567932157 | chr5:42040791-42040792 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528492175 | chr5:42040862-42040863 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181601177 | chr5:42040920-42040921 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571412289 | chr5:42040938-42040939 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538708708 | chr5:42040972-42040973 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs141157359 | chr5:42040985-42040986 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568760066 | chr5:42040996-42040997 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536427397 | chr5:42041062-42041063 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143586990 | chr5:42041089-42041090 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554315521 | chr5:42041168-42041169 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573061078 | chr5:42041205-42041206 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533553684 | chr5:42041219-42041220 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs186561121 | chr5:42041249-42041250 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546047513 | chr5:42041294-42041295 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576897361 | chr5:42041362-42041363 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146795563 | chr5:42041368-42041369 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527523115 | chr5:42041398-42041399 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78494732 | chr5:42041416-42041417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562546945 | chr5:42041430-42041431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190282798 | chr5:42041462-42041463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543172414 | chr5:42041477-42041478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs79060991 | chr5:42041479-42041480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181973452 | chr5:42041515-42041516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs276306 | chr5:42041524-42041525 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs186360163 | chr5:42041550-42041551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564980804 | chr5:42041577-42041578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hepatocellular carcinoma | 18929564 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:42038200-42041000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
2 | chr5:42040000-42041400 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr5:42041000-42041600 | Enhancers | HUES64 Cell Line | embryonic stem cell |